0001121702-23-000071.txt : 20231115 0001121702-23-000071.hdr.sgml : 20231115 20231115165953 ACCESSION NUMBER: 0001121702-23-000071 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20231115 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: YIELD10 BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001121702 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 043158289 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33133 FILM NUMBER: 231411345 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 201 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 617-583-1700 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 201 CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX, INC. DATE OF NAME CHANGE: 20060717 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX INC DATE OF NAME CHANGE: 20000810 8-K 1 yten-20231115.htm 8-K yten-20231115
0001121702FALSE00011217022023-11-152023-11-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 
Date of Report (Date of earliest event reported) November 15, 2023
 
YIELD10 BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)
 

Delaware001-3313304-3158289
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
19 Presidential Way, Woburn, Massachusetts
 01801
(Address of principal executive offices)(Zip Code)
 
Registrant’s Telephone Number, Including Area Code: (617) 583-1700 
N/A 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.01 per shareYTEN
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o





Item 8.01 Other Events.
On November 15, 2023, Yield10 Bioscience, Inc. issued press releases announcing that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s Biotechnology Regulatory Services had determined that Yield10’s glufosinate-tolerant Camelina sativa ("Camelina”) and stacked herbicide-tolerant Camelina may be grown and bred in the United States.
A copy of the press releases are attached hereto as Exhibit 99.1 and Exhibit 99.2.
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit  
No. Description
 
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  YIELD10 BIOSCIENCE, INC.
   
November 15, 2023By:/s/ Oliver P. Peoples
  Oliver P. Peoples
  President & Chief Executive Officer


EX-99.1 2 exhibit991-ytenx20231115xx.htm EX-99.1 Document

yield10logoa50.jpg

Exhibit 99.1
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
-Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils
-On Track for Commercial Launch of Glufosinate Tolerant Camelina as early as 2025
WOBURN, Mass. – November 15, 2023 – Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s glufosinate tolerant Camelina sativa ("Camelina”) may be grown and bred in the United States. Yield10 submitted a Request for Regulatory Status Review (“RSR”) to the BRS under the SECURE Rule in June 2022 for glufosinate tolerant Camelina. The response from USDA-APHIS means that the agency does not consider the modified Camelina plant to be an increased plant pest risk as compared to unmodified Camelina and is therefore not subject to regulation under 7 CFR part 340 regulations. Yield10’s submission along with the USDA-APHIS BRS response is posted on the USDA’s website.
“The regulatory clearance of glufosinate tolerant Camelina through USDA-APHIS represents a significant commercial milestone for Yield10,” said Kristi Snell, Ph.D., Chief Scientific Officer of Yield10 Bioscience. “Our approach to developing elite Camelina varieties is based on introducing new traits into the crop to benefit growers. We believe glufosinate tolerant Camelina will provide growers with new options for weed management allowing Camelina to fit seamlessly into crop rotations driving commercial adoption. We are building seed inventory of our spring glufosinate tolerant Camelina to support commercial launch as early as 2025 to support grower contracts to produce low-carbon feedstock oil for the biofuel market.”
“Decarbonizing transportation biofuels and identifying scalable replacements for depleted fish oil sources of omega-3 fatty acids for health and nutrition represent major societal challenges and will require sustainable agriculture solutions based on all of the advanced genetic tools available for improving crop productivity, in particular stacking genetic traits using combinations of gene editing and traditional genetic engineering methods,” said Oliver Peoples, Ph.D., Chief Executive Officer of Yield10 Bioscience. “We believe this first approval from USDA-APHIS for HT Camelina is a major commercial milestone that reinforces our commitment to using best-in-class advanced gene technologies to improve the performance and economic value of the Camelina crop. Our spring E3902 HT Camelina variety embodies this approach combining eight gene edits to boost oil content along with the gene conferring herbicide tolerance introduced using traditional genetic engineering methods. Stacking new traits in Camelina will enable us to expand our portfolio of commercial Camelina varieties available to growers.”
Peoples continued, “With over 30 years of safety experience with biotech crops in the U.S., we’re pleased to see the science-based approach codified in the SECURE Rule to evaluate and confirm the regulatory status of well-studied traits deployed into new crops. This framework also enables clarity around the regulatory path early in the development of new traits, enabling close alignment of



the timing for the confirmation of regulatory status, seed production ramp-up and commercial launch planning.”
Glufosinate, a broad-spectrum Class 10 herbicide, is used to protect seed yield by controlling broadleaf weeds during commercial crop production. In August 2022, Yield10 reported that the Company had observed good herbicide tolerance to glufosinate in its candidate Camelina lines and chose lead lines for commercial development. Yield10 is currently scaling-up seed inventory in anticipation of the commercial launch of glufosinate tolerant Camelina. Yield10 is also developing Camelina stacked HT traits combining tolerance to glufosinate along with tolerance to Group 2 soil residual herbicide to produce a robust weed control package for growers of the crop. Yield10 is developing elite varieties of Camelina to supply under grower contracts to produce feedstock oils for the biofuel market and to produce omega-3 (EPA, DHA) oils for use as pharmaceutical, nutritional and animal feed ingredients.
About the SECURE Rule
The SECURE Rule was published on May 18, 2020 and represented the first comprehensive revision of APHIS’ biotechnology regulations since 1987. The revisions enable APHIS to regulate organisms developed using genetic engineering for plant pest risk with greater precision and reduced regulatory burden for developers of organisms that are unlikely to pose plant pest risks. Once a specific plant developed through genetic engineering is found not to require regulation, new varieties of the plant containing the same genetic modification would similarly not be regulated. Camelina plants containing herbicide tolerance traits are subject to labeling under EPA regulations.
About Yield10 Bioscience
Yield10 Bioscience, Inc. ("Yield10" or the "Company") is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa ("Camelina") as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics. Our commercial plan is based on establishing a grain contracting business leveraging our proprietary elite Camelina seed varieties, focusing on the growing demand for low-carbon intensity feedstock oil for biofuels and omega-3 oils for nutritional applications. Yield10 is headquartered in Woburn, MA and has a Canadian subsidiary, Yield10 Oilseeds Inc., located in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com, or follow the Company on X (formerly Twitter), Facebook and LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, those relating to the Company’s planned scaling up of seed inventory and timing for the commercial launch of glufosinate-tolerant Camelina; whether deployment of a robust herbicide tolerance package in Camelina will be attractive to growers and drive commercial



adoption of the crop; and whether the Company’s work in Camelina will improve the performance and economic value of the crop, including its potential to allow for sustainable production of feedstock oils, omega-3 oils and PHA bioplastics, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR
Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

EX-99.2 3 exhibit992-ytenx20231115xx.htm EX-99.2 Document

yield10logoa50a.jpg
Exhibit 99.2

USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States
-Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North America
WOBURN, Mass. – November 15, 2023 – Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s (“USDA-APHIS’s”) Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s stacked herbicide tolerant (“HT”) Camelina sativa ("Camelina”) may be grown and bred in the United States. In April 2023, Yield10 submitted Request for Confirmation of Regulatory Status packages to the BRS under the Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient (“SECURE”) Rule, for stacked HT Camelina varieties. The response from USDA-APHIS means that the agency does not consider the modified Camelina varieties to be an increased plant pest risk as compared to unmodified Camelina] and are therefore not subject to regulation under 7 CFR part 340 regulations. Yield10’s submissions along with the USDA-APHIS BRS responses are posted on the USDA’s website.
Yield10 is developing stacked HT Camelina varieties with tolerance to the application of glufosinate, a Group 10 herbicide used to control broadleaf weeds, as well as tolerance to soil residues of Group 2 herbicides, specifically including tolerance to both imidazolinones (“IMIs”) and sulfonylureas (“SUs”). Group 2 herbicides are commonly used to manage weeds in cereal and pulse crop rotations and can persist in the soil for months following use. Yield10 is executing a program to develop and commercialize spring and winter Camelina varieties with stacked herbicide tolerance traits to achieve large-acreage adoption of the crop in North America.
“The regulatory clearance of our stacked HT Camelina represents another significant commercial milestone achieved by the Yield10 team, underscoring our commitment to establishing both technical and commercial leadership positions in Camelina,” said Kristi Snell, Ph.D., Chief Scientific Officer of Yield10 Bioscience. “Earlier this year, we conducted our first field tests of stacked HT Camelina and reported positive results. Going forward, we expect to generate additional field data as well as build seed inventory to support the commercial launch of our stacked HT Camelina varieties.”
“Our team has done outstanding work advancing the development and commercialization of HT and stacked HT Camelina,” said Oliver Peoples, Ph.D., Chief Executive Officer of Yield10 Bioscience. “We expect these varieties to form the centerpiece of our portfolio of elite Camelina varieties that our team will be able to offer to growers and will be critical to enabling the cultivation of Camelina on large acreage in North America. Our commercial strategy is to advance our leadership position in Camelina by innovating to bring forward new value-added traits to the Camelina crop that provide meaningful improvements in yield, agronomic, and economic performance to the grower.”
About the SECURE Rule
The SECURE Rule was published on May 18, 2020 and represented the first comprehensive revision of APHIS’ biotechnology regulations since 1987. The revisions enable APHIS to regulate organisms developed using genetic engineering for plant pest risk with greater



precision and reduced regulatory burden for developers of organisms that are unlikely to pose plant pest risks. Once a specific plant developed through genetic engineering is found not to require regulation, new varieties of the plant containing the same genetic modification would similarly not be regulated. Camelina plants containing herbicide tolerance traits are subject to labeling under EPA regulations.
About Yield10 Bioscience
Yield10 Bioscience, Inc. ("Yield10" or the "Company") is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa ("Camelina") as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics. Our commercial plan is based on establishing a grain contracting business leveraging our proprietary elite Camelina seed varieties, focusing on the growing demand for low-carbon intensity feedstock oil for biofuels and omega-3 oils for nutritional applications. Yield10 is headquartered in Woburn, MA and has a Canadian subsidiary, Yield10 Oilseeds Inc., located in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com, or follow the Company on X (formerly Twitter), Facebook and LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, those relating to the Company’s plans for the continued development and commercial launch of herbicide tolerant Camelina; whether deployment of a robust herbicide tolerance package in Camelina will be attractive to growers, allow for large-acreage cultivation of Camelina and drive commercial adoption of the crop; and whether the Company’s work in Camelina will improve the performance and economic value of the crop, including its potential to allow for sustainable production of feedstock oils, omega-3 oils and PHA bioplastics, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR



Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

EX-101.SCH 4 yten-20231115.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 yten-20231115_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 6 yten-20231115_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 yield10logoa50.jpg begin 644 yield10logoa50.jpg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yield10logoa50a.jpg begin 644 yield10logoa50a.jpg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htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 15, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Nov. 15, 2023
Entity Registrant Name YIELD10 BIOSCIENCE, INC.
Entity File Number 001-33133
Entity Tax Identification Number 04-3158289
Entity Address, Address Line One 19 Presidential Way
Entity Address, City or Town Woburn
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01801
City Area Code 617
Local Phone Number 583-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Central Index Key 0001121702
Amendment Flag false
Title of 12(b) Security Common stock, par value $0.01 per share
Trading Symbol YTEN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

XML 10 yten-20231115_htm.xml IDEA: XBRL DOCUMENT 0001121702 2023-11-15 2023-11-15 0001121702 false 8-K 2023-11-15 YIELD10 BIOSCIENCE, INC. 001-33133 04-3158289 19 Presidential Way Woburn MA 01801 617 583-1700 false false false false Common stock, par value $0.01 per share YTEN NASDAQ false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 21 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://yield10bio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports yten-20231115.htm yten-20231115.xsd yten-20231115_lab.xml yten-20231115_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "yten-20231115.htm": { "nsprefix": "yten", "nsuri": "http://yield10bio.com/20231115", "dts": { "inline": { "local": [ "yten-20231115.htm" ] }, "schema": { "local": [ "yten-20231115.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "labelLink": { "local": [ "yten-20231115_lab.xml" ] }, "presentationLink": { "local": [ "yten-20231115_pre.xml" ] } }, "keyStandard": 21, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2022": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 21 }, "report": { "R1": { "role": "http://yield10bio.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "yten-20231115.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "yten-20231115.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://yield10bio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 18 0001121702-23-000071-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001121702-23-000071-xbrl.zip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end